{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:58:01Z","timestamp":1791903481500,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s13402-020-00571-z","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T08:02:55Z","timestamp":1605772975000},"page":"357-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["AKR1C3 is a biomarker and druggable target for oropharyngeal tumors"],"prefix":"10.1007","volume":"44","author":[{"given":"Caterina","family":"Peraldo-Neia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ostano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizia","family":"Mello-Grand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Guana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Gregnanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Boschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Oliaro-Bosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese Chiara","family":"Pippione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Carenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris","family":"De Cecco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cavalieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Micali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Averono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bagnasacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Dosdegani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Masini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Krengli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Aluffi-Valletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9502-6400","authenticated-orcid":false,"given":"Giovanna","family":"Chiorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"571_CR1","doi-asserted-by":"crossref","first-page":"xi","DOI":"10.1016\/j.otc.2012.05.003","volume":"45","author":"SI Pai","year":"2012","unstructured":"S.I. Pai, HPV-associated head and neck cancers. Otolaryngol. Clin. N. Am. 45, xi\u2013xii (2012)","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"571_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics. CA Cancer J. Clin. 69, 7\u201334 (2019)","journal-title":"CA Cancer J. Clin."},{"key":"571_CR3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fonc.2017.00072","volume":"7","author":"A Argiris","year":"2017","unstructured":"A. Argiris, K.J. Harrington, M. Tahara, J. Schulten, P. Chomette, A. Ferreira Castro, L. Licitra, Evidence-based treatment options in recurrent and\/or metastatic squamous cell carcinoma of the head and neck. Front. Oncol. 7, 72 (2017)","journal-title":"Front. Oncol."},{"key":"571_CR4","first-page":"7350","volume":"62","author":"KK Ang","year":"2002","unstructured":"K.K. Ang, B.A. Berkey, X. Tu, H.Z. Zhang, R. Katz, E.H. Hammond, K.K. Fu, L.L. Milas, Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res. 62, 7350\u20137356 (2002)","journal-title":"Cancer Res."},{"key":"571_CR5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11864-011-0176-y","volume":"13","author":"KA Price","year":"2012","unstructured":"K.A. Price, E.E. Cohen, Current treatment options for metastatic head and neck cancer. Curr. Treat. Options in Oncol. 13, 35\u201346 (2012)","journal-title":"Curr. Treat. Options in Oncol."},{"key":"571_CR6","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/hed.24803","volume":"39","author":"CC Hung","year":"2017","unstructured":"C.C. Hung, C.Y. Chien, P.Y. Chu, Y.J. Wu, C.S. Lin, C.J. Huang, L.P. Chan, Y.Y. Wang, S.F. Yuan, T.C. Hour, J.Y. Chen, Differential resistance to platinum-based drugs and 5-fluorouracil in p22phox-overexpressing oral squamous cell carcinoma: Implications of alternative treatment strategies. Head Neck 39, 1621\u20131630 (2017)","journal-title":"Head Neck"},{"key":"571_CR7","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S1470-2045(17)30421-7","volume":"18","author":"KJ Harrington","year":"2017","unstructured":"K.J. Harrington, R.L. Ferris, G. Blumenschein, A.D. Colevas, J. Fayette, L. Licitra, S. Kasper, C. Even, E.E. Vokes, F. Worden, N.F. Saba, N. Kiyota, R. Haddad, M. Tahara, V. Gr\u00fcnwald, J.W. Shaw, M. Monga, M. Lynch, F. Taylor, M. DeRosa, L. Morrissey, K. Cocks, M.L. Gillison, J. Guigay, Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. Lancet Oncol. 18, 1104\u20131115 (2017)","journal-title":"Lancet Oncol."},{"key":"571_CR8","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","volume":"375","author":"RL Ferris","year":"2016","unstructured":"R.L. Ferris, G. Blumenschein, J. Fayette, J. Guigay, A.D. Colevas, L. Licitra, K. Harrington, S. Kasper, E.E. Vokes, C. Even, F. Worden, N.F. Saba, L.C. Iglesias Docampo, R. Haddad, T. Rordorf, N. Kiyota, M. Tahara, M. Monga, M. Lynch, W.J. Geese, J. Kopit, J.W. Shaw, M.L. Gillison, Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 375, 1856\u20131867 (2016)","journal-title":"N. Engl. J. Med."},{"key":"571_CR9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1102\/1470-7330.2010.0008","volume":"10","author":"DW Tshering Vogel","year":"2010","unstructured":"D.W. Tshering Vogel, P. Zbaeren, H.C. Thoeny, Cancer of the oral cavity and oropharynx. Cancer Imaging 10, 62\u201372 (2010)","journal-title":"Cancer Imaging"},{"key":"571_CR10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.oraloncology.2008.05.018","volume":"45","author":"S Petti","year":"2009","unstructured":"S. Petti, Lifestyle risk factors for oral cancer. Oral Oncol. 45, 340\u2013350 (2009)","journal-title":"Oral Oncol."},{"key":"571_CR11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.oraloncology.2009.04.001","volume":"45","author":"AD Rapidis","year":"2009","unstructured":"A.D. Rapidis, P. Gullane, J.D. Langdon, J.L. Lefebvre, C. Scully, J.P. Shah, Major advances in the knowledge and understanding of the epidemiology, aetiopathogenesis, diagnosis, management and prognosis of oral cancer. Oral Oncol. 45, 299\u2013300 (2009)","journal-title":"Oral Oncol."},{"key":"571_CR12","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0140-6736(04)16194-1","volume":"363","author":"ML Gillison","year":"2004","unstructured":"M.L. Gillison, D.R. Lowy, A causal role for human papillomavirus in head and neck cancer. Lancet 363, 1488\u20131489 (2004)","journal-title":"Lancet"},{"key":"571_CR13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ijc.10960","volume":"104","author":"JM Ritchie","year":"2003","unstructured":"J.M. Ritchie, E.M. Smith, K.F. Summersgill, H.T. Hoffman, D. Wang, J.P. Klussmann, L.P. Turek, T.H. Haugen, Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int. J. Cancer 104, 336\u2013344 (2003)","journal-title":"Int. J. Cancer"},{"key":"571_CR14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","volume":"100","author":"C Fakhry","year":"2008","unstructured":"C. Fakhry, W.H. Westra, S. Li, A. Cmelak, J.A. Ridge, H. Pinto, A. Forastiere, M.L. Gillison, Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl. Cancer Inst. 100, 261\u2013269 (2008)","journal-title":"J. Natl. Cancer Inst."},{"key":"571_CR15","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"CGA Network","year":"2015","unstructured":"C.G.A. Network, Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576\u2013582 (2015)","journal-title":"Nature"},{"key":"571_CR16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1078-0432.CCR-13-3310","volume":"21","author":"TY Seiwert","year":"2015","unstructured":"T.Y. Seiwert, Z. Zuo, M.K. Keck, A. Khattri, C.S. Pedamallu, T. Stricker, C. Brown, T.J. Pugh, P. Stojanov, J. Cho, M.S. Lawrence, G. Getz, J. Br\u00e4gelmann, R. DeBoer, R.R. Weichselbaum, A. Langerman, L. Portugal, E. Blair, K. Stenson, M.W. Lingen, E.E. Cohen, E.E. Vokes, K.P. White, P.S. Hammerman, Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin. Cancer Res. 21, 632\u2013641 (2015)","journal-title":"Clin. Cancer Res."},{"key":"571_CR17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/archoto.2008.540","volume":"135","author":"P Lohavanichbutr","year":"2009","unstructured":"P. Lohavanichbutr, J. Houck, W. Fan, B. Yueh, E. Mendez, N. Futran, D.R. Doody, M.P. Upton, D.G. Farwell, S.M. Schwartz, L.P. Zhao, C. Chen, Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer: Potential implications for treatment choices. Arch. Otolaryngol. Head Neck Surg. 135, 180\u2013188 (2009)","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"571_CR18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ijc.30081","volume":"139","author":"T Guo","year":"2016","unstructured":"T. Guo, D.A. Gaykalova, M. Considine, S. Wheelan, A. Pallavajjala, J.A. Bishop, W.H. Westra, T. Ideker, W.M. Koch, Z. Khan, E.J. Fertig, J.A. Califano, Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma. Int. J. Cancer 139, 373\u2013382 (2016)","journal-title":"Int. J. Cancer"},{"key":"571_CR19","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/annonc\/mdu173","volume":"25","author":"L De Cecco","year":"2014","unstructured":"L. De Cecco, P. Bossi, L. Locati, S. Canevari, L. Licitra, Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor. Ann. Oncol. 25, 1628\u20131635 (2014)","journal-title":"Ann. Oncol."},{"key":"571_CR20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1158\/1078-0432.CCR-14-2481","volume":"21","author":"MK Keck","year":"2015","unstructured":"M.K. Keck, Z. Zuo, A. Khattri, T.P. Stricker, C.D. Brown, M. Imanguli, D. Rieke, K. Endhardt, P. Fang, J. Br\u00e4gelmann, R. DeBoer, M. El-Dinali, S. Aktolga, Z. Lei, P. Tan, S.G. Rozen, R. Salgia, R.R. Weichselbaum, M.W. Lingen, M.D. Story, K.K. Ang, E.E. Cohen, K.P. White, E.E. Vokes, T.Y. Seiwert, Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. Clin. Cancer Res. 21, 870\u2013881 (2015)","journal-title":"Clin. Cancer Res."},{"key":"571_CR21","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1002\/ijc.31954","volume":"144","author":"CU Huebbers","year":"2019","unstructured":"C.U. Huebbers, F. Verhees, L. Poluschkin, N.C. Olthof, J. Kolligs, O.G. Siefer, M. Henfling, F.C.S. Ramaekers, S.F. Preuss, D. Beutner, J. Seehawer, U. Drebber, Y. Korkmaz, W.L. Lam, E.A. Vucic, B. Kremer, J.P. Klussmann, E.M. Speel, Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis. Int. J. Cancer 144, 2465\u20132477 (2019)","journal-title":"Int. J. Cancer"},{"key":"571_CR22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13046-019-1256-2","volume":"38","author":"WM Chang","year":"2019","unstructured":"W.M. Chang, Y.C. Chang, Y.C. Yang, S.K. Lin, P.M. Chang, M. Hsiao, AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1\/3 signaling pathway. J. Exp. Clin. Cancer Res. 38, 245 (2019)","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"571_CR23","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1038\/sj.onc.1210953","volume":"27","author":"R Cangemi","year":"2008","unstructured":"R. Cangemi, A. Mensah, V. Albertini, A. Jain, M. Mello-Grand, G. Chiorino, C.V. Catapano, G.M. Carbone, Reduced expression and tumor suppressor function of the ETS transcription factor ESE-3 in prostate cancer. Oncogene\u00a027, 2877\u20132885 (2008)","journal-title":"Oncogene."},{"key":"571_CR24","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1002\/ijc.29649","volume":"137","author":"G Wichmann","year":"2015","unstructured":"G. Wichmann, M. Rosolowski, K. Krohn, M. Kreuz, A. Boehm, A. Reiche, U. Scharrer, D. Halama, J. Bertolini, U. Bauer, D. Holzinger, M. Pawlita, J. Hess, C. Engel, D. Hasenclever, M. Scholz, P. Ahnert, H. Kirsten, A. Hemprich, C. Wittekind, O. Herbarth, F. Horn, A. Dietz, M. Loeffler, (LHNG) LHaNG, The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer. Int. J. Cancer 137, 2846\u20132857 (2015)","journal-title":"Int. J. Cancer"},{"key":"571_CR25","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ejmech.2018.03.040","volume":"150","author":"AC Pippione","year":"2018","unstructured":"A.C. Pippione, I.M. Carnovale, D. Bonanni, M. Sini, P. Goyal, E. Marini, K. Pors, S. Adinolfi, D. Zonari, C. Festuccia, W.Y. Wahlgren, R. Friemann, R. Bagnati, D. Boschi, S. Oliaro-Bosso, M.L. Lolli, Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: Application of a bioisosteric scaffold hopping approach to flufenamic acid. Eur. J. Med. Chem. 150, 930\u2013945 (2018)","journal-title":"Eur. J. Med. Chem."},{"key":"571_CR26","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.18632\/oncotarget.27249","volume":"10","author":"I Shaikh","year":"2019","unstructured":"I. Shaikh, A. Ansari, G. Ayachit, M. Gandhi, P. Sharma, S. Bhairappanavar, C.G. Joshi, J. Das, Differential gene expression analysis of HNSCC tumors deciphered tobacco dependent and independent molecular signatures. Oncotarget\u00a010, 6168\u20136183 (2019)","journal-title":"Oncotarget."},{"key":"571_CR27","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1200\/JCO.2016.68.2955","volume":"34","author":"A Chakravarthy","year":"2016","unstructured":"A. Chakravarthy, S. Henderson, S.M. Thirdborough, C.H. Ottensmeier, X. Su, M. Lechner, A. Feber, G.J. Thomas, T.R. Fenton, Human papillomavirus drives tumor development throughout the head and neck: Improved prognosis is associated with an immune response largely restricted to the oropharynx. J. Clin. Oncol. 34, 4132\u20134141 (2016)","journal-title":"J. Clin. Oncol."},{"key":"571_CR28","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/cancers11081057","volume":"26","author":"LD Locati","year":"2019","unstructured":"L.D. Locati, M.S. Serafini, M.F. Iann\u00f2, A. Carenzo, E. Orlandi, C. Resteghin, S. Cavalieri, P. Bossi, S. Canevari, L. Licitra, L. De Cecco, Mining of self-organizing map gene-expression portraits reveals prognostic stratification of HPV-positive head and neck squamous cell carcinoma. Cancers\u00a026, 1057 (2019)","journal-title":"Cancers"},{"key":"571_CR29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1541-7786.MCR-17-0153","volume":"16","author":"LA Koneva","year":"2018","unstructured":"L.A. Koneva, Y. Zhang, S. Virani, P.B. Hall, J.B. McHugh, D.B. Chepeha, G.T. Wolf, T.E. Carey, L.S. Rozek, M.A. Sartor, HPV integration in HNSCC correlates with survival outcomes, immune response signatures, and candidate drivers. Mol. Cancer Res. 16, 90\u2013102 (2018)","journal-title":"Mol. Cancer Res."},{"key":"571_CR30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40425-019-0662-5","volume":"7","author":"EEW Cohen","year":"2019","unstructured":"E.E.W. Cohen, R.B. Bell, C.B. Bifulco, B. Burtness, M.L. Gillison, K.J. Harrington, Q.T. Le, N.Y. Lee, R. Leidner, R.L. Lewis, L. Licitra, H. Mehanna, L.K. Mell, A. Raben, A.G. Sikora, R. Uppaluri, F. Whitworth, D.P. Zandberg, R.L. Ferris, The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC). J. Immunother. Cancer 7, 184 (2019)","journal-title":"J. Immunother. Cancer"},{"key":"571_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13577-010-0004-x","volume":"24","author":"M Suzuki","year":"2011","unstructured":"M. Suzuki, H. Ishikawa, A. Tanaka, I. Mataga, Heterogeneity of anticancer drug sensitivity in squamous cell carcinoma of the tongue. Hum.Cell. 24, 21\u201329 (2011)","journal-title":"Hum.Cell."},{"key":"571_CR32","doi-asserted-by":"crossref","unstructured":"S. L\u00f3pez-Verd\u00edn, J. Lavalle-Carrasco, R.G. Carre\u00f3n-Burciaga, N. Seraf\u00edn-Higuera, N. Molina-Frechero, R. Gonz\u00e1lez-Gonz\u00e1lez, R. Bologna-Molina, Molecular markers of anticancer drug resistance in head and neck squamous cell carcinoma: A literature review. Cancers\u00a010, 376 (2018)","DOI":"10.3390\/cancers10100376"},{"key":"571_CR33","doi-asserted-by":"crossref","first-page":"2597581","DOI":"10.1155\/2017\/2597581","volume":"2017","author":"A Leone","year":"2017","unstructured":"A. Leone, M.S. Roca, C. Ciardiello, S. Costantini, A. Budillon, Oxidative stress gene expression profile correlates with Cancer patient poor prognosis: Identification of crucial pathways might select novel therapeutic approaches. Oxidative Med. Cell. Longev. 2017, 2597581 (2017)","journal-title":"Oxidative Med. Cell. Longev."},{"key":"571_CR34","doi-asserted-by":"crossref","first-page":"3907147","DOI":"10.1155\/2016\/3907147","volume":"2016","author":"M Tafani","year":"2016","unstructured":"M. Tafani, L. Sansone, F. Limana, T. Arcangeli, E. De Santis, M. Polese, M. Fini, M.A. Russo, The interplay of reactive oxygen species, hypoxia, inflammation, and Sirtuins in Cancer initiation and progression. Oxidative Med. Cell. Longev. 2016, 3907147 (2016)","journal-title":"Oxidative Med. Cell. Longev."},{"key":"571_CR35","doi-asserted-by":"crossref","unstructured":"C. Nicco, F. Batteux, ROS modulator molecules with therapeutic potential in cancers treatments. Molecules 23, 84 (2017)","DOI":"10.3390\/molecules23010084"},{"key":"571_CR36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","volume":"10","author":"JE Visvader","year":"2012","unstructured":"J.E. Visvader, G.J. Lindeman, Cancer stem cells: Current status and evolving complexities. Cell Stem Cell 10, 717\u2013728 (2012)","journal-title":"Cell Stem Cell"},{"key":"571_CR37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13073-018-0569-7","volume":"10","author":"VK Kartha","year":"2018","unstructured":"V.K. Kartha, K.A. Alamoud, K. Sadykov, B.C. Nguyen, F. Laroche, H. Feng, J. Lee, S.I. Pai, X. Varelas, A.M. Egloff, J.E. Snyder-Cappione, A.C. Belkina, M.V. Bais, S. Monti, M.A. Kukuruzinska, Functional and genomic analyses reveal therapeutic potential of targeting \u03b2-catenin\/CBP activity in head and neck cancer. Genome Med. 10, 54 (2018)","journal-title":"Genome Med."},{"key":"571_CR38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00784-013-0967-6","volume":"18","author":"H Hanken","year":"2014","unstructured":"H. Hanken, A. Gr\u00f6be, G. Cachovan, R. Smeets, R. Simon, G. Sauter, M. Heiland, M. Blessmann, CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas. Clin. Oral Investig. 18, 269\u2013276 (2014)","journal-title":"Clin. Oral Investig."},{"key":"571_CR39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12916-017-0929-y","volume":"15","author":"JP Foy","year":"2017","unstructured":"J.P. Foy, L. Bazire, S. Ortiz-Cuaran, S. Deneuve, J. Kielbassa, E. Thomas, A. Viari, A. Puisieux, P. Goudot, C. Bertolus, N. Foray, Y. Kirova, P. Verrelle, P. Saintigny, A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes. BMC Med. 15, 165 (2017)","journal-title":"BMC Med."},{"key":"571_CR40","doi-asserted-by":"crossref","first-page":"86503","DOI":"10.18632\/oncotarget.21220","volume":"8","author":"Y Wang","year":"2017","unstructured":"Y. Wang, Y. Liu, H. Liu, Q. Zhang, H. Song, J. Tang, J. Fu, X. Wang, FcGBP was upregulated by HPV infection and correlated to longer survival time of HNSCC patients. Oncotarget 8, 86503\u201386514 (2017)","journal-title":"Oncotarget"},{"key":"571_CR41","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/cas.12809","volume":"106","author":"L Masterson","year":"2015","unstructured":"L. Masterson, F. Sorgeloos, D. Winder, M. Lechner, A. Marker, S. Malhotra, H. Sudhoff, P. Jani, P. Goon, J. Sterling, Deregulation of SYCP2 predicts early stage human papillomavirus-positive oropharyngeal carcinoma: A prospective whole transcriptome analysis. Cancer Sci. 106, 1568\u20131575 (2015)","journal-title":"Cancer Sci."},{"key":"571_CR42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ejca.2006.09.001","volume":"43","author":"I Martinez","year":"2007","unstructured":"I. Martinez, J. Wang, K.F. Hobson, R.L. Ferris, S.A. Khan, Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur. J. Cancer 43, 415\u2013432 (2007)","journal-title":"Eur. J. Cancer"},{"key":"571_CR43","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/hed.25623","volume":"41","author":"MA Pav\u00f3n","year":"2019","unstructured":"M.A. Pav\u00f3n, I. Arroyo-Solera, X. Le\u00f3n, M. T\u00e9llez-Gabriel, D. Vir\u00f3s, A.A. Gallardo, M.V. C\u00e9spedes, I. Casanova, A. Lopez-Pousa, A. Barnadas, M.M. Quer, R. Mangues, The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial-like head and neck carcinoma subtypes. Head Neck 41, 1830\u20131845 (2019)","journal-title":"Head Neck"},{"key":"571_CR44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12105-014-0597-6","volume":"9","author":"BJ Thibodeau","year":"2015","unstructured":"B.J. Thibodeau, T.J. Geddes, L.E. Fortier, S. Ahmed, B.L. Pruetz, J. Wobb, P. Chen, G.D. Wilson, J.A. Akervall, Gene expression characterization of HPV positive head and neck cancer to predict response to chemoradiation. Head Neck Pathol. 9, 345\u2013353 (2015)","journal-title":"Head Neck Pathol."},{"key":"571_CR45","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/jcmm.14040","volume":"23","author":"SL He","year":"2019","unstructured":"S.L. He, W.P. Wang, Y.S. Yang, E.M. Li, L.Y. Xu, L.Q. Chen, FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition. J. Cell. Mol. Med. 23, 1375\u20131385 (2019)","journal-title":"J. Cell. Mol. Med."},{"key":"571_CR46","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.canlet.2012.09.026","volume":"328","author":"Z Li","year":"2013","unstructured":"Z. Li, H. Mou, T. Wang, J. Xue, B. Deng, L. Qian, Y. Zhou, W. Gong, J.M. Wang, G. Wu, C.F. Zhou, J. Fang, Y. Le, A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating slug expression. Cancer Lett. 328, 278\u2013284 (2013)","journal-title":"Cancer Lett."},{"key":"571_CR47","doi-asserted-by":"crossref","first-page":"41131","DOI":"10.1038\/srep41131","volume":"7","author":"WM Chang","year":"2017","unstructured":"W.M. Chang, Y.F. Lin, C.Y. Su, H.Y. Peng, Y.C. Chang, J.R. Hsiao, C.L. Chen, J.Y. Chang, Y.S. Shieh, M. Hsiao, S.G. Shiah, Parathyroid hormone-like hormone is a poor prognosis marker of head and neck cancer and promotes cell growth via RUNX2 regulation. Sci. Rep. 7, 41131 (2017)","journal-title":"Sci. Rep."},{"key":"571_CR48","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13046-014-0100-y","volume":"33","author":"Z Lv","year":"2014","unstructured":"Z. Lv, X. Wu, W. Cao, Z. Shen, L. Wang, F. Xie, J. Zhang, T. Ji, M. Yan, W. Chen, Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma. J. Exp. Clin. Cancer Res. 33, 100 (2014)","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"571_CR49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12105-016-0685-x","volume":"10","author":"L Puzzo","year":"2016","unstructured":"L. Puzzo, R. Caltabiano, R. Parenti, S. Trapasso, E. Allegra, Connexin 43 (Cx43) expression in laryngeal squamous cell carcinomas: Preliminary data on its possible prognostic role. Head Neck Pathol. 10, 292\u2013297 (2016)","journal-title":"Head Neck Pathol."},{"key":"571_CR50","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1089\/gtmb.2012.0524","volume":"17","author":"L Varisli","year":"2013","unstructured":"L. Varisli, Identification of new genes downregulated in prostate cancer and investigation of their effects on prognosis. Genet. Test. Mol. Biomark. 17, 562\u2013566 (2013)","journal-title":"Genet. Test. Mol. Biomark."},{"key":"571_CR51","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2353\/ajpath.2006.050384","volume":"168","author":"K Ikeda","year":"2006","unstructured":"K. Ikeda, K. Iyama, N. Ishikawa, H. Egami, M. Nakao, Y. Sado, Y. Ninomiya, H. Baba, Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region. Am. J. Pathol. 168, 856\u2013865 (2006)","journal-title":"Am. J. Pathol."},{"key":"571_CR52","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.7150\/jca.28636","volume":"9","author":"Y Zhou","year":"2018","unstructured":"Y. Zhou, J. Xiang, A. Bhandari, Y. Guan, E. Xia, X. Zhou, Y. Wang, O. Wang, CLDN10 is associated with papillary thyroid Cancer progression. J. Cancer 9, 4712\u20134717 (2018)","journal-title":"J. Cancer"},{"key":"571_CR53","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/hepr.12500","volume":"45","author":"H Sun","year":"2015","unstructured":"H. Sun, C. Cui, F. Xiao, H. Wang, J. Xu, X. Shi, Y. Yang, Q. Zhang, X. Zheng, X. Yang, C. Wu, L. Wang, miR-486 regulates metastasis and chemosensitivity in hepatocellular carcinoma by targeting CLDN10 and CITRON. Hepatol. Res. 45, 1312\u20131322 (2015)","journal-title":"Hepatol. Res."},{"key":"571_CR54","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cbi.2012.09.024","volume":"202","author":"T Matsunaga","year":"2013","unstructured":"T. Matsunaga, A. Hojo, Y. Yamane, S. Endo, O. El-Kabbani, A. Hara, Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers. Chem. Biol. Interact. 202, 234\u2013242 (2013)","journal-title":"Chem. Biol. Interact."},{"key":"571_CR55","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1021\/acsmedchemlett.8b00484","volume":"10","author":"ML Lolli","year":"2019","unstructured":"M.L. Lolli, I.M. Carnovale, A.C. Pippione, W.Y. Wahlgren, D. Bonanni, E. Marini, D. Zonari, M. Gallicchio, V. Boscaro, P. Goyal, R. Friemann, B. Rolando, R. Bagnati, S. Adinolfi, S. Oliaro-Bosso, D. Boschi, Bioisosteres of indomethacin as inhibitors of Aldo-Keto Reductase 1C3. ACS Med. Chem. Lett. 10, 437\u2013443 (2019)","journal-title":"ACS Med. Chem. Lett."},{"key":"571_CR56","doi-asserted-by":"crossref","first-page":"48050","DOI":"10.18632\/oncotarget.10347","volume":"7","author":"SQ Sun","year":"2016","unstructured":"S.Q. Sun, X. Gu, X.S. Gao, Y. Li, H. Yu, W. Xiong, W. Wang, Y. Teng, D. Zhou, Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation. Oncotarget 7, 48050\u201348058 (2016)","journal-title":"Oncotarget"},{"key":"571_CR57","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ejmech.2017.08.046","volume":"139","author":"AC Pippione","year":"2017","unstructured":"A.C. Pippione, A. Giraudo, D. Bonanni, I.M. Carnovale, E. Marini, C. Cena, A. Costale, D. Zonari, K. Pors, M. Sadiq, D. Boschi, S. Oliaro-Bosso, M.L. Lolli, Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach. Eur. J. Med. Chem. 139, 936\u2013946 (2017)","journal-title":"Eur. J. Med. Chem."},{"key":"571_CR58","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1158\/1535-7163.MCT-17-1023","volume":"17","author":"K Verma","year":"2018","unstructured":"K. Verma, N. Gupta, T. Zang, P. Wangtrakluldee, S.K. Srivastava, T.M. Penning, P.C. Trippier, AKR1C3 inhibitor KV-37 exhibits antineoplastic effects and potentiates Enzalutamide in combination therapy in prostate adenocarcinoma cells. Mol. Cancer Ther. 17, 1833\u20131845 (2018)","journal-title":"Mol. Cancer Ther."},{"key":"571_CR59","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/cgt.2013.15","volume":"20","author":"L Xie","year":"2013","unstructured":"L. Xie, J. Yu, W. Guo, L. Wei, Y. Liu, X. Wang, X. Song, Aldo-keto reductase 1C3 may be a new radioresistance marker in non-small-cell lung cancer. Cancer Gene Ther. 20, 260\u2013266 (2013)","journal-title":"Cancer Gene Ther."},{"key":"571_CR60","doi-asserted-by":"crossref","first-page":"e111911","DOI":"10.1371\/journal.pone.0111911","volume":"9","author":"W Xiong","year":"2014","unstructured":"W. Xiong, J. Zhao, H. Yu, X. Li, S. Sun, Y. Li, Q. Xia, C. Zhang, Q. He, X. Gao, L. Zhang, D. Zhou, Elevated expression of AKR1C3 increases resistance of cancer cells to ionizing radiation via modulation of oxidative stress. PLoS One 9, e111911 (2014)","journal-title":"PLoS One"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-020-00571-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13402-020-00571-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-020-00571-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T11:05:36Z","timestamp":1616411136000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13402-020-00571-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["571"],"URL":"https:\/\/doi.org\/10.1007\/s13402-020-00571-z","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]},"assertion":[{"value":"21 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed involving human participants were in accordance with the ethical standards of the Ethical Committee of Novara University Hospital (Protocol No. CE42\/2011) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}